Yanbin Wang
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 10%
- CAR-T cell therapy research
- Pancreatic and Hepatic Oncology Research
Papers in
- Surgery 5
- Trauma Management and Diagnosis 2
- Co-authors
- Ran Xue (3 shared papers)Jianyu Hao (3 shared papers)Jianxin Wang (2 shared papers)Shanshan Yin (3 shared papers)Minhua Chen (3 shared papers)Kai Jia (1 shared paper)Lingyun Gao (1 shared paper)Jiangtao Ren (1 shared paper)
- Journals
- Oxidative Medicine and Cellular Longevity (2 papers)Tissue and Cell (2 papers)Experimental Eye Research (1 paper)Organic Geochemistry (1 paper)Clinical Neurology and Neurosurgery (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Yanbin Wang
47 papers receiving 786 citations
Yanbin Wang's Hit Papers
Peers
Comparison fields: 5 of 96
- Hepatology 72
- Oncology 232
- Immunology 93
- Molecular Biology 232
- Aging 6
Countries citing papers authored by Yanbin Wang
This map shows the geographic impact of Yanbin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanbin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanbin Wang more than expected).
Fields of papers citing papers by Yanbin Wang
This network shows the impact of papers produced by Yanbin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanbin Wang. The network helps show where Yanbin Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yanbin Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia Hit paper breakdown → | 2021 | 214 |
| 2 | 2018 | 86 | |
| 3 | 2006 | 61 | |
| 4 | 2020 | 56 | |
| 5 | 2018 | 48 | |
| 6 | 2019 | 40 | |
| 7 | 2019 | 36 | |
| 8 | 2012 | 30 | |
| 9 | 2019 | 28 | |
| 10 | 2011 | 22 | |
| 11 | 2019 | 20 | |
| 12 | [Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation]. | 2005 | 16 |
| 13 | 2021 | 16 | |
| 14 | 2019 | 16 | |
| 15 | 2022 | 13 | |
| 16 | 2016 | 10 | |
| 17 | 2020 | 8 | |
| 18 | 2022 | 8 | |
| 19 | 2023 | 6 | |
| 20 | 2015 | 6 |
About Yanbin Wang
Yanbin Wang is a scholar working on Molecular Biology, Surgery, Epidemiology, Pulmonary and Respiratory Medicine and Ophthalmology, having authored 50 papers that have together received 797 indexed citations. Recurring topics across this work include Medicinal plant effects and applications (2 papers), Urinary Bladder and Prostate Research (2 papers), Traumatic Ocular and Foreign Body Injuries (2 papers), Trauma Management and Diagnosis (2 papers), Autophagy in Disease and Therapy (2 papers), Neurogenesis and neuroplasticity mechanisms (1 paper), Streptococcal Infections and Treatments (1 paper) and Digital Imaging for Blood Diseases (1 paper). The work is most often cited by research in Hepatology (72 citations), Oncology (232 citations), Immunology (93 citations), Molecular Biology (232 citations) and Aging (6 citations). Yanbin Wang has collaborated with scholars based in China and United States. Frequent co-authors include Ran Xue, Jianyu Hao, Jianxin Wang, Shanshan Yin, Minhua Chen, Kai Jia, Lingyun Gao, Jiangtao Ren, He Huang and Ming Gao. Their work appears in journals such as Oxidative Medicine and Cellular Longevity, Tissue and Cell, Experimental Eye Research, Organic Geochemistry and Clinical Neurology and Neurosurgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.